The fastest way to turn a pet shampoo launch into a regulatory project is a single word on the label: kills. In the United States, a grooming product that claims to kill fleas or ticks is regulated as a pesticide and needs EPA registration. In the European Union, the same claim pulls the product into the Biocidal Products Regulation. The product itself may be identical — the claim is what changes the regulatory world it lives in. This guide maps the lines, so a DTC brand can position a pet grooming line on the simple side of them.
Why pet grooming sits outside cosmetic rules
Unlike human skincare, pet grooming products are not covered by the EU Cosmetics Regulation, nor by the detergents regulation, and in the US they generally sit outside FDA cosmetic rules. That sounds like freedom — and mostly it is: a plain cleansing shampoo is a general consumer product. But the frameworks that do apply are real: the EU's General Product Safety Regulation sets the baseline safety obligations, and the moment a claim crosses into pest control, a specialized regime takes over.
The claim line in the US: EPA
A product that claims to kill pests is treated as a pesticide and must be registered with the EPA before sale — registration that carries data requirements, timelines and costs that a grooming brand did not budget for. A product positioned as a repellent-care spray — keeping pests away rather than killing them — is assessed differently. The distinction is in the verbs: kill, eliminate and eradicate are regulatory words; repel, care for and maintain are grooming words. Final classification always rests with the agency's reading of the label, which is why the claim set should be drafted deliberately, not inherited from a supplier's Chinese-language marketing deck.
The claim line in the EU: BPR and GPSR
The same verbs draw the same line in the EU. Treated with biocidal claims, a product falls under the Biocidal Products Regulation with its active-substance approval requirements; positioned as a grooming product, it travels under the General Product Safety Regulation with labeling and documentation duties instead. Pet grooming products are also outside the EU Cosmetics Regulation — which surprises brands that assume the human-cosmetics rulebook transfers to pet products.
Practical positioning for natural-formula lines
Plant-based repellent-care products occupy the practical middle ground: a formula built on botanical extracts can be positioned around coat care, odor control and keeping pests away — without kill claims — and is the positioning commonly chosen to stay on the simpler regulatory path in both markets. The label copy, the listing copy and the advertising should all use the same verb set, because a compliant label with a kill-claim advertisement still creates exposure. Brands should draft the claim set once, deliberately, and reuse it everywhere.
Frequently Asked Questions
Does a pet shampoo need FDA approval in the US?
Ordinary pet grooming products generally sit outside FDA cosmetic rules. The regulatory trigger to watch is claims: pest-control claims move the product into EPA pesticide territory. Pure cleansing and coat-care claims stay on the general product path.
Is a natural formula automatically compliant in the EU?
No — compliance follows the claim, not the ingredient list. A botanical formula that claims to kill germs or pests can still trigger the Biocidal Products Regulation. Position the product as grooming care and let the ingredient story support it without crossing the line.
Can we say the product repels fleas?
Repellent-care positioning is the common compliant choice for natural-formula products, but the final classification always rests with the destination authority's reading of the label. Draft the claim set with your regulatory support, and keep label, listing and advertising consistent.
Who is responsible for the claims — the brand or the factory?
Shared, in practice. The brand owns the market-facing claims; the factory owns the formula facts that must back them. A manufacturer who flags claim risks during product development — before the label is printed — is showing the compliance maturity that protects both sides.Claim-safe formulation support belongs inside that conversation from the first development brief.